- Home
- IVD
- By Technology Types
- By Diseases Types
- By Product Types
- Research
- Resource
- Distributors
- Company
| Product Name | Anti-BAFF-Binding Receptor (TACI) Capture Antibody |
| Catalog No. | RDMA-0321 |
| Description | A high-performance capture antibody for TACI (CD267), essential for monitoring BAFF/APRIL signaling pathways and B-cell dysregulation in SLE patients. |
| Category | SLE Marker |
| Host Species | Mouse |
| Clonality | Monoclonal |
| Isotype | IgG1 |
| Form | Liquid |
| Concentration | 2.5 mg/mL |
| Purity | >98% |
| Purification | Protein A |
| Buffer | 0.01M PBS |
| Preservative | 0.05% ProClin |
| Application | ELISA/CLIA |
| Matching Antigen | Recombinant TACI |
| Sensitivity | High |
| Specificity | No BCMA cross |
| CV (%) | <3% |
| Storage | 2-8°C |
| Shelf Life | 48 Months |
| Stability | 15x Cycles |
| Titer | 1:1.5M |
| Protein Test | UV280 |
| Endotoxin | <0.1 EU/mg |
For research use only, not for clinical use.
|
There is no product in your cart. |